Skip to content

Prospective Study of Liver Mobilization With the Levita Magnetic Surgical System

Prospective Study of Liver Mobilization With the Levita Magnetic Surgical System

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03508674
Enrollment
54
Registered
2018-04-26
Start date
2018-04-20
Completion date
2018-09-06
Last updated
2024-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bariatric Surgery Candidate

Brief summary

The purpose of this study is to evaluate the safety and effectiveness of the Levita Magnetic Surgical System in patients undergoing bariatric procedures

Detailed description

Prospective, multicenter, single-arm, open label study designed to assess the safety and effectiveness of the Levita Magnetic Surgical System in bariatric procedures.

Interventions

use of surgical tool

Sponsors

Levita Magnetics
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* at least 18 years of age * scheduled to undergo bariatric procedure

Exclusion criteria

* Am Soc Anesthesiology score of III or IV * significant comorbidities * subjects contraindicated for use of magnetic system * clinical history of impaired coagulation * hepatic abnormality or anatomical abnormality

Design outcomes

Primary

MeasureTime frameDescription
Number and Types of Additional Tools Required to Mobilize the Liver During ProcedureDuring planned bariatric procedure. (approximately 2 hours on a single day.)The ability to mobilize the liver will be evaluated by recording the number and types of additional tools used to mobilize the liver during a bariatric procedure. If another tool besides the Magnetic Surgical System (MSS) is required to move the liver then the use of the MSS has not been successful.
Number of Participants With Adverse Events and Device Related Adverse EventsThrough 30 days post bariatric procedureAll adverse events will be recorded and allocated as to relatedness to device, procedure or other.

Countries

Chile

Participant flow

Participants by arm

ArmCount
Intervention
Levita Magnetic Surgical System Levita Magnetic Surgical System: use of surgical tool
54
Total54

Baseline characteristics

CharacteristicIntervention
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
54 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
54 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Region of Enrollment
Chile
54 participants
Sex: Female, Male
Female
49 Participants
Sex: Female, Male
Male
5 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 54
other
Total, other adverse events
15 / 54
serious
Total, serious adverse events
2 / 54

Outcome results

Primary

Number and Types of Additional Tools Required to Mobilize the Liver During Procedure

The ability to mobilize the liver will be evaluated by recording the number and types of additional tools used to mobilize the liver during a bariatric procedure. If another tool besides the Magnetic Surgical System (MSS) is required to move the liver then the use of the MSS has not been successful.

Time frame: During planned bariatric procedure. (approximately 2 hours on a single day.)

ArmMeasureValue (NUMBER)
InterventionNumber and Types of Additional Tools Required to Mobilize the Liver During Procedure0 Additional Tools to Mobilize Liver
Primary

Number of Participants With Adverse Events and Device Related Adverse Events

All adverse events will be recorded and allocated as to relatedness to device, procedure or other.

Time frame: Through 30 days post bariatric procedure

ArmMeasureGroupValue (NUMBER)
InterventionNumber of Participants With Adverse Events and Device Related Adverse EventsTotal Participants With Adverse Events17 participants
InterventionNumber of Participants With Adverse Events and Device Related Adverse EventsParticipants With Adverse Events Related to Device14 participants

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026